Cargando…
Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease
Alternative splicing of pre-mRNA contributes strongly to the diversity of cell- and tissue-specific protein expression patterns. Global transcriptome analyses have suggested that >90% of human multiexon genes are alternatively spliced. Alterations in the splicing process cause missplicing events...
Autores principales: | Suñé-Pou, Marc, Limeres, María J., Moreno-Castro, Cristina, Hernández-Munain, Cristina, Suñé-Negre, Josep M., Cuestas, María L., Suñé, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373156/ https://www.ncbi.nlm.nih.gov/pubmed/32760425 http://dx.doi.org/10.3389/fgene.2020.00731 |
Ejemplares similares
-
Targeting Splicing in the Treatment of Human Disease
por: Suñé-Pou, Marc, et al.
Publicado: (2017) -
ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery
por: Hueso, Miguel, et al.
Publicado: (2021) -
Comparative Analysis of the Physicochemical and Biological Characteristics of Freeze-Dried PEGylated Cationic Solid Lipid Nanoparticles
por: Narváez-Narváez, David A., et al.
Publicado: (2023) -
Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy
por: Suñé-Pou, Marc, et al.
Publicado: (2018) -
Prp40 pre-mRNA processing factor 40 homolog B (PRPF40B) associates with SF1 and U2AF(65) and modulates alternative pre-mRNA splicing in vivo
por: Becerra, Soraya, et al.
Publicado: (2015)